Legend Biotech (LEGN) Cash & Equivalents (2019 - 2026)
Legend Biotech's Cash & Equivalents came in at $672.9 million for Q2 2026, down 30.5% from $967.6 million a year earlier but up 4.1% from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Legend Biotech's Cash & Equivalents was $901.9 million, up 214.6% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 12.3% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $286.7 million in FY2024 (-78.2%), $1.31 billion in FY2023 (+56.0%), $841.32 million in FY2022 (-2.0%) and $858.61 million in FY2021 (+69.7%).
- The five-year range for quarterly Cash & Equivalents is $278.89 million (Q3 2025) to $1.33 billion (Q2 2023).
- Year-over-year, Cash & Equivalents increased in 1 of the last eight quarters, with an average decline of 5.6%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2025 (growth of 214.6%), and the weakest in Q4 2024 (a decline of 78.2%).
- Business Quant data shows LEGN's Cash & Equivalents at $646.4 million (Q1 2026), $901.9 million (Q4 2025) and $278.89 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Legend Biotech | 3.42 Bn | -317.56 Mn | 251.50 Mn | 672.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 672.90 Mn |
| Mar 31, 2026 | 646.40 Mn |
| Dec 31, 2025 | 901.90 Mn |
| Sep 30, 2025 | 278.89 Mn |
| Jun 30, 2025 | 967.60 Mn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 286.70 Mn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.31 Bn |
| Sep 30, 2023 | 1.24 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 670.07 Mn |
| Dec 31, 2022 | 786.03 Mn |
| Sep 30, 2022 | 1.03 Bn |
| Jun 30, 2022 | 788.98 Mn |
| Mar 31, 2022 | 667.47 Mn |
| Dec 31, 2021 | 688.94 Mn |
| Sep 30, 2021 | 338.33 Mn |
API Access
Legend Biotech Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();